NCT02862470View on ClinicalTrials.gov

Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

August 5, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

August 24, 2020

Conditions
Thyroid Cancer
All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT02862470 - Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients | Biotech Hunter | Biotech Hunter